MetaCap

Q/C Technologies Inc. (QCLS)

NASDAQ: QCLSHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

0.2784-0.0178 (-6.01%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

QCLS stock chart

Technical analysis

Key statistics

All statistics
52-week range
0.275 – 8.17
Day range
0.275 – 0.3205
Volume / Avg
126.00K / 5.05M
Beta
—

52-week range

$0.275$8.17

QCLS stock today

On Nov 20, QCLS ended the session at $0.2784, shedding $0.0178 (6.01%), versus the S&P 500's 3.70% decline. Trading was light, with 126.00K shares changing hands, about 2% of the average daily volume. Shares are 96.6% below their 52-week high of $8.17 and 1.2% above the 52-week low of $0.275, near the bottom of the past year's range.

Q/C Technologies trades at 0.1x its trailing twelve-month earnings per share of $4.69.

Summary generated from market data by MetaCap's automated system. Methodology

About Q/C Technologies

Company profile

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments.

Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Headquarters
New York, NY
Employees
3
IPO year
2014

Financial highlights

Full financials

Q/C Technologies reported a net loss of $11.6 million, compared with a loss of $23.4 million a year earlier. Diluted earnings per share came in at -$8.66.

Q/C Technologies annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue—————
Growth—————
Net income$-11.63M$-23.36M$-4.00M$-15.20M$-29.89M
EPS (diluted)$-8.66$-1,080.87$-5.33$-11.74—

Earnings

Earnings history
Last reported (Sep/2026)
Nov 18, 2026
EPS actual vs est.
$-0.14 vs —

QCLS news

All QCLS news

Q/C Technologies peers

Health Care sector
QCLS peer companies
CompanyPrice% ChgMarket capCompare
VRAXVirax Biolabs Group Limited0.3319-12.89%$446.40Kvs QCLS
CDIOCardio Diagnostics Holdings Inc.1.60-3.03%$4.74Mvs QCLS
BMRABiomerica Inc.1.08-0.92%$4.97Mvs QCLS
TRIBTrinity Biotech plc ADR6.24+13.76%$5.07Mvs QCLS
VNRXVolitionRX Limited0.1621-1.58%$5.85Mvs QCLS
IMDXInsight Molecular Diagnostics Inc.1.97+18.67%$80.88Mvs QCLS
ICCCImmuCell Corporation10.92-2.41%$99.28Mvs QCLS
NNNNAnbio Biotechnology Class A3.32-9.04%$145.72Mvs QCLS

Indexes, lists and sector

Q/C Technologies stock FAQ

What is Q/C Technologies's stock price today?

QCLS last traded at $0.2784 as of Nov 20, 4:00 PM EST, down 6.01% on the day. Prices are delayed at least 15 minutes.

What is QCLS's P/E ratio?

QCLS trades at a trailing P/E ratio of 0.06.

What is the QCLS 52-week high?

The 52-week high for QCLS is $8.17 and the 52-week low is $0.275. The stock is currently 96.6% below its high.

Compare QCLS